← FDA DRUG APPROVALS

FDA ANDA · ANDA088549

CHLORPROPAMIDE

Sponsor: PHARMOBEDIENT

APPLICATION
ANDA088549
TYPE
ANDA
ORIGINAL APPROVAL
1984-06-01
LATEST ACTION
2009-11-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CHLORPROPAMIDEDiscontinued
CHLORPROPAMIDE 100MG · TABLET · ORAL
CHLORPROPAMIDEDiscontinued
CHLORPROPAMIDE 250MG · TABLET · ORAL

Approval history

2009-11-16Labeling · Supplement 18AP
2003-08-06Labeling · Supplement 14AP
1998-02-25Manufacturing (CMC) · Supplement 13AP
1998-02-05Manufacturing (CMC) · Supplement 12AP
1997-07-07Manufacturing (CMC) · Supplement 11AP
1993-11-03Manufacturing (CMC) · Supplement 10AP
1991-06-11Labeling · Supplement 8AP
1990-01-31Manufacturing (CMC) · Supplement 7AP
1989-07-31Labeling · Supplement 6AP
1988-03-04Manufacturing (CMC) · Supplement 5AP
1984-06-01OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →